Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma

NCT02969473 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Neoplasm
Chemoradiation

Interventions

DRUG: Docetaxel
DRUG: Fluorouracil

Sponsor

Zhu Yujia